BioLife Solutions, Inc. Deferred Income Tax Expense (Benefit)
BioLife Solutions, Inc. (BLFS) reported Deferred Income Tax Expense (Benefit) of -$42.42 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2026-08-06
- BioLife Solutions, Inc. deferred income tax expense (benefit) for the quarter ending 2026-06-30 was -$42.43M, a 94391.11% decline year-over-year.
- BioLife Solutions, Inc. deferred income tax expense (benefit) for the quarter ending 2026-03-31 was $9.00K, a 50.00% increase year-over-year.
- BioLife Solutions, Inc. deferred income tax expense (benefit) for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- BioLife Solutions, Inc. deferred income tax expense (benefit) for the quarter ending 2025-09-30 was $14.00K.
- BioLife Solutions, Inc. deferred income tax expense (benefit) for fiscal 2025 was $65.00K.
- BioLife Solutions, Inc. deferred income tax expense (benefit) for fiscal 2024 was -$64.00K.
- BioLife Solutions, Inc. deferred income tax expense (benefit) for fiscal 2023 was -$62.00K.
- BioLife Solutions, Inc. deferred income tax expense (benefit) for fiscal 2022 was -$5.24M.
| Period end | Deferred Income Tax Expense (Benefit) 3 month | Deferred Income Tax Expense (Benefit) 6 month | Deferred Income Tax Expense (Benefit) 9 month | Deferred Income Tax Expense (Benefit) 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$42.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$42.42M 10-Q · filed 2026-08-06 | -$42.42M derived: sum of 3 quarters · filed 2026-08-06 | -$42.41M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $9.00K 10-Q · filed 2026-05-07 | $9.00K derived: sum of 2 quarters · filed 2026-05-07 | $23.00K derived: sum of 3 quarters · filed 2026-05-07 | $68.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $14.00K derived: sum of 2 quarters · filed 2026-02-26 | $59.00K derived: sum of 3 quarters · filed 2026-08-06 | $65.00K 10-K · filed 2026-02-26 |
| 2025-09-30 | $14.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $59.00K derived: sum of 2 quarters · filed 2026-08-06 | $65.00K 10-Q · filed 2025-11-06 | $89.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $45.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $51.00K 10-Q · filed 2026-08-06 | $75.00K derived: sum of 3 quarters · filed 2026-08-06 | -$18.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $6.00K 10-Q · filed 2026-05-07 | $30.00K derived: sum of 2 quarters · filed 2026-05-07 | -$63.00K derived: sum of 3 quarters · filed 2026-05-07 | -$63.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $24.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$69.00K derived: sum of 2 quarters · filed 2026-02-26 | -$69.00K derived: sum of 3 quarters · filed 2026-02-26 | -$64.00K 10-K · filed 2026-02-26 |
| 2024-09-30 | -$93.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$93.00K derived: sum of 2 quarters · filed 2025-11-06 | -$88.00K 10-Q · filed 2025-11-06 | -$186.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $5.00K 10-Q · filed 2025-08-07 | -$93.00K derived: sum of 3 quarters · filed 2026-02-26 | -$70.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $5.00K 10-Q · filed 2025-05-08 | -$93.00K derived: sum of 2 quarters · filed 2026-02-26 | -$70.00K derived: sum of 3 quarters · filed 2026-02-26 | -$70.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | -$98.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$75.00K derived: sum of 2 quarters · filed 2026-02-26 | -$75.00K derived: sum of 3 quarters · filed 2026-02-26 | -$62.00K 10-K · filed 2026-02-26 |
| 2023-09-30 | $23.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $23.00K derived: sum of 2 quarters · filed 2024-11-12 | $36.00K 10-Q · filed 2024-11-12 | -$265.00K derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $13.00K 10-Q · filed 2024-08-09 | -$288.00K derived: sum of 3 quarters · filed 2025-03-03 | -$887.00K derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-03-31 | $13.00K 10-Q · filed 2024-05-10 | -$288.00K derived: sum of 2 quarters · filed 2025-03-03 | -$887.00K derived: sum of 3 quarters · filed 2025-03-03 | -$4.63M derived: sum of 4 quarters · filed 2025-03-03 |
| 2022-12-31 | -$301.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | -$900.00K derived: sum of 2 quarters · filed 2025-03-03 | -$4.64M derived: sum of 3 quarters · filed 2025-03-03 | -$5.24M 10-K · filed 2025-03-03 |
| 2022-09-30 | -$599.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$4.34M derived: sum of 2 quarters · filed 2023-11-09 | -$4.94M 10-Q · filed 2023-11-09 | -$7.52M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | -$3.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$4.34M 10-Q · filed 2023-08-09 | -$6.92M derived: sum of 3 quarters · filed 2024-02-29 | -$11.91M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | -$599.00K 10-Q · filed 2023-05-11 | -$3.19M derived: sum of 2 quarters · filed 2024-02-29 | -$8.17M derived: sum of 3 quarters · filed 2024-02-29 | -$20.73M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | -$2.59M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | -$7.58M derived: sum of 2 quarters · filed 2024-02-29 | -$20.13M derived: sum of 3 quarters · filed 2024-02-29 | -$20.13M 10-K · filed 2024-02-29 |
| 2021-09-30 | -$4.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$17.54M derived: sum of 2 quarters · filed 2022-11-09 | -$17.54M 10-Q · filed 2022-11-09 | -$20.84M derived: sum of 4 quarters · filed 2023-03-31 |
| 2021-06-30 | -$12.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$12.55M 10-Q · filed 2022-08-09 | -$15.85M derived: sum of 3 quarters · filed 2023-03-31 | -$15.85M derived: sum of 4 quarters · filed 2023-03-31 |
| 2021-03-31 | $0.00 10-Q · filed 2022-05-10 | -$3.30M derived: sum of 2 quarters · filed 2023-03-31 | -$3.30M derived: sum of 3 quarters · filed 2023-03-31 | |
| 2020-12-31 | -$3.30M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$3.30M derived: sum of 2 quarters · filed 2023-03-31 | -$3.30M 10-K · filed 2023-03-31 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $0.00 10-Q · filed 2021-11-15 | ||
| 2020-06-30 | $0.00 10-Q · filed 2021-08-16 | |||
| 2019-12-31 | -$1.54M 10-K · filed 2022-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B |